Skip to main content
. 2014 Mar 21;8(4):783–798. doi: 10.1016/j.molonc.2014.03.008

Figure 4.

Figure 4

A schematic representation of recommended techniques to use for antibody validation in mainstream biomarker development projects, oriented towards clinical application.